A Study Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Persons
Clinical trial NCT06298032 · COMPLETED
Trial details
- NCT number
- NCT06298032
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-20
- Primary completion
- 2024-11-15
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.